LARISSA HAFNER: Open Payments
NPI 1588398150 · SAN ANTONIO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,023 in 76 payments from 22 companies in 2025. Trend: 2023 $1,301 · 2024 $2,777 · 2025 $2,023
Food & beverage: $2,023
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $525 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $342 |
| AstraZeneca Pharmaceuticals LP | 13 | $324 |
| Phathom Pharmaceuticals, Inc. | 1 | $121 |
| SANOFI-AVENTIS U.S. LLC | 5 | $107 |
| SI-BONE, INC. | 1 | $85 |
| Dexcom, Inc. | 3 | $61 |
| PFIZER INC. | 3 | $49 |
| Amgen Inc. | 2 | $49 |
| Janssen Pharmaceuticals, Inc | 1 | $44 |
Products named: Kerendia, Ozempic, AIRSUPRA, VOQUEZNA, TZIELD, BREZTRI, Rybelsus, Dexcom G6 Transmitter.
Industry payments across TX — which companies pay providers there.
